1-N-(1-adamantyl)-2-N-cyclohexyl-4-(4-methyl-1,3-oxazol-2-yl)benzene-1,2-diamine;2-N-cyclohexyl-5-(3-methyl-1,2,4-oxadiazol-5-yl)-3-N-pentan-3-ylpyridine-2,3-diamine;2-N,3-N-dicyclohexyl-5-(4-methyl-1,3-oxazol-2-yl)pyridine-2,3-diamine;2-N,3-N-dicyclopentyl-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridine-2,3-diamine

C84H119N17O4 — CID 162184271

IUPAC1-N-(1-adamantyl)-2-N-cyclohexyl-4-(4-methyl-1,3-oxazol-2-yl)benzene-1,2-diamine;2-N-cyclohexyl-5-(3-methyl-1,2,4-oxadiazol-5-yl)-3-N-pentan-3-ylpyridine-2,3-diamine;2-N,3-N-dicyclohexyl-5-(4-methyl-1,3-oxazol-2-yl)pyridine-2,3-diamine;2-N,3-N-dicyclopentyl-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridine-2,3-diamine
SMILESCCC(CC)Nc1cc(-c2nc(C)no2)cnc1NC1CCCCC1.Cc1coc(-c2ccc(NC34CC5CC(CC(C5)C3)C4)c(NC3CCCCC3)c2)n1.Cc1coc(-c2cnc(NC3CCCCC3)c(NC3CCCCC3)c2)n1.Cc1noc(-c2cnc(NC3CCCC3)c(NC3CCCC3)c2)n1
InChIInChI=1S/C26H35N3O.C21H30N4O.C19H29N5O.C18H25N5O/c1-17-16-30-25(27-17)21-7-8-23(24(12-21)28-22-5-3-2-4-6-22)29-26-13-18-9-19(14-26)11-20(10-18)15-26;1-15-14-26-21(23-15)16-12-19(24-17-8-4-2-5-9-17)20(22-13-16)25-18-10-6-3-7-11-18;1-4-15(5-2)22-17-11-14(19-21-13(3)24-25-19)12-20-18(17)23-16-9-7-6-8-10-16;1-12-20-18(24-23-12)13-10-16(21-14-6-2-3-7-14)17(19-11-13)22-15-8-4-5-9-15/h7-8,12,16,18-20,22,28-29H,2-6,9-11,13-15H2,1H3;12-14,17-18,24H,2-11H2,1H3,(H,22,25);11-12,15-16,22H,4-10H2,1-3H3,(H,20,23);10-11,14-15,21H,2-9H2,1H3,(H,19,22)
InChIKeyZPLJYUMANZIKKL-UHFFFAOYSA-N
MW1430.99 g/mol
LogP21.24
Rot. Bonds22

About 1-N-(1-adamantyl)-2-N-cyclohexyl-4-(4-methyl-1,3-oxazol-2-yl)benzene-1,2-diamine;2-N-cyclohexyl-5-(3-methyl-1,2,4-oxadiazol-5-yl)-3-N-pentan-3-ylpyridine-2,3-diamine;2-N,3-N-dicyclohexyl-5-(4-methyl-1,3-oxazol-2-yl)pyridine-2,3-diamine;2-N,3-N-dicyclopentyl-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridine-2,3-diamine

1-N-(1-adamantyl)-2-N-cyclohexyl-4-(4-methyl-1,3-oxazol-2-yl)benzene-1,2-diamine;2-N-cyclohexyl-5-(3-methyl-1,2,4-oxadiazol-5-yl)-3-N-pentan-3-ylpyridine-2,3-diamine;2-N,3-N-dicyclohexyl-5-(4-methyl-1,3-oxazol-2-yl)pyridine-2,3-diamine;2-N,3-N-dicyclopentyl-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridine-2,3-diamine (PubChem CID 162184271) has the molecular formula C84H119N17O4 and a molecular weight of 1430.99 g/mol. Its IUPAC name is 1-N-(1-adamantyl)-2-N-cyclohexyl-4-(4-methyl-1,3-oxazol-2-yl)benzene-1,2-diamine;2-N-cyclohexyl-5-(3-methyl-1,2,4-oxadiazol-5-yl)-3-N-pentan-3-ylpyridine-2,3-diamine;2-N,3-N-dicyclohexyl-5-(4-methyl-1,3-oxazol-2-yl)pyridine-2,3-diamine;2-N,3-N-dicyclopentyl-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridine-2,3-diamine.

Molecular Properties

Compound Name1-N-(1-adamantyl)-2-N-cyclohexyl-4-(4-methyl-1,3-oxazol-2-yl)benzene-1,2-diamine;2-N-cyclohexyl-5-(3-methyl-1,2,4-oxadiazol-5-yl)-3-N-pentan-3-ylpyridine-2,3-diamine;2-N,3-N-dicyclohexyl-5-(4-methyl-1,3-oxazol-2-yl)pyridine-2,3-diamine;2-N,3-N-dicyclopentyl-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridine-2,3-diamine
PubChem CID162184271
Molecular FormulaC84H119N17O4
Molecular Weight1430.99 g/mol
Exact Mass1429.96
IUPAC Name1-N-(1-adamantyl)-2-N-cyclohexyl-4-(4-methyl-1,3-oxazol-2-yl)benzene-1,2-diamine;2-N-cyclohexyl-5-(3-methyl-1,2,4-oxadiazol-5-yl)-3-N-pentan-3-ylpyridine-2,3-diamine;2-N,3-N-dicyclohexyl-5-(4-methyl-1,3-oxazol-2-yl)pyridine-2,3-diamine;2-N,3-N-dicyclopentyl-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridine-2,3-diamine
SMILESCCC(CC)Nc1cc(-c2nc(C)no2)cnc1NC1CCCCC1.Cc1coc(-c2ccc(NC34CC5CC(CC(C5)C3)C4)c(NC3CCCCC3)c2)n1.Cc1coc(-c2cnc(NC3CCCCC3)c(NC3CCCCC3)c2)n1.Cc1noc(-c2cnc(NC3CCCC3)c(NC3CCCC3)c2)n1
InChIInChI=1S/C26H35N3O.C21H30N4O.C19H29N5O.C18H25N5O/c1-17-16-30-25(27-17)21-7-8-23(24(12-21)28-22-5-3-2-4-6-22)29-26-13-18-9-19(14-26)11-20(10-18)15-26;1-15-14-26-21(23-15)16-12-19(24-17-8-4-2-5-9-17)20(22-13-16)25-18-10-6-3-7-11-18;1-4-15(5-2)22-17-11-14(19-21-13(3)24-25-19)12-20-18(17)23-16-9-7-6-8-10-16;1-12-20-18(24-23-12)13-10-16(21-14-6-2-3-7-14)17(19-11-13)22-15-8-4-5-9-15/h7-8,12,16,18-20,22,28-29H,2-6,9-11,13-15H2,1H3;12-14,17-18,24H,2-11H2,1H3,(H,22,25);11-12,15-16,22H,4-10H2,1-3H3,(H,20,23);10-11,14-15,21H,2-9H2,1H3,(H,19,22)
InChIKeyZPLJYUMANZIKKL-UHFFFAOYSA-N
XLogP21.24
TPSA264.81 Ų
H-Bond Donors8
H-Bond Acceptors21
Rotatable Bonds22
Heavy Atoms105
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001430.99
LogP ≤ 521.24
H-Bond Donors ≤ 58
H-Bond Acceptors ≤ 1021

Analyze 1-N-(1-adamantyl)-2-N-cyclohexyl-4-(4-methyl-1,3-oxazol-2-yl)benzene-1,2-diamine;2-N-cyclohexyl-5-(3-methyl-1,2,4-oxadiazol-5-yl)-3-N-pentan-3-ylpyridine-2,3-diamine;2-N,3-N-dicyclohexyl-5-(4-methyl-1,3-oxazol-2-yl)pyridine-2,3-diamine;2-N,3-N-dicyclopentyl-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridine-2,3-diamine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

6-[2-(Cyclopenten-1-yl)ethynyl]-8-[2-(dimethylamino)ethyl]-2-(4-piperidin-4-yloxyanilino)pyrido[2,3-d]pyrimidin-7-one;6-(2-cyclopentylethynyl)-2-[4-(1-methylpyrrolidin-3-yl)oxyanilino]-8-[(5-phenyl-1,3-oxazol-4-yl)methyl]pyrido[2,3-d]pyrimidin-7-one;8-[(5-cyclopentyl-1,2-oxazol-4-yl)methyl]-6-(2-ethoxyethynyl)-2-(4-piperidin-3-yloxyanilino)pyrido[2,3-d]pyrimidin-7-one;6-(3-methylbut-1-ynyl)-2-[4-(4-methylmorpholin-2-yl)anilino]-8-[[1-(trifluoromethyl)imidazol-2-yl]methyl]pyrido[2,3-d]pyrimidin-7-one
CID 161476673
2-(1,3-dimethyl-2,6-dioxopurin-7-yl)-N-[4-[4-[[3-methyl-7-[2-[4-(1,3-oxazol-2-yl)anilino]-2-oxoethyl]-2,6-dioxopurin-1-yl]methyl]-2-pyridinyl]phenyl]acetamide
CID 135163499
N,N-dimethyl-3-(3-pyridin-4-yl-1,2,4-oxadiazol-5-yl)aniline;5-[3-(furan-2-yl)phenyl]-3-pyridin-4-yl-1,2,4-oxadiazole;N-methyl-3-(3-pyridin-4-yl-1,2,4-oxadiazol-5-yl)aniline;5-[3-(1,3-oxazol-4-yl)phenyl]-3-pyridin-4-yl-1,2,4-oxadiazole;3-pyridin-4-yl-5-(3-pyrrolidin-1-ylphenyl)-1,2,4-oxadiazole;3-pyridin-4-yl-5-(4-pyrrolidin-1-ylphenyl)-1,2,4-oxadiazole
CID 157843586
2-phenyl-3-propan-2-ylpyridine;2-phenyl-5-propan-2-ylpyridine;2-phenyl-6-propan-2-ylpyridine;3-phenyl-2-propan-2-ylpyridine;3-phenyl-5-propan-2-ylpyridine;4-phenyl-2-propan-2-ylpyridine;4-phenyl-3-propan-2-ylpyridine;5-phenyl-2-propan-2-ylpyridine;6-propan-2-ylfuro[2,3-b]pyridine;6-propan-2-ylfuro[3,2-b]pyridine;5-propan-2-yl-1H-imidazo[4,5-b]pyridine;6-propan-2-yl-1H-imidazo[4,5-b]pyridine;5-propan-2-yl-[1,3]oxazolo[5,4-b]pyridine;6-propan-2-yl-[1,3]oxazolo[4,5-b]pyridine;6-propan-2-yl-1H-pyrrolo[2,3-b]pyridine;6-propan-2-yl-1H-pyrrolo[3,2-b]pyridine
CID 158232279
[6-Methyl-3-(3-methyl-1,2,4-oxadiazol-5-yl)-2-pyridinyl]-[2-[(5-methyl-2-pyridinyl)oxymethyl]-7-azabicyclo[2.2.1]heptan-7-yl]methanone;[6-methyl-3-(3-methyl-2-pyridinyl)-2-pyridinyl]-[2-[(5-methyl-2-pyridinyl)oxymethyl]-7-azabicyclo[2.2.1]heptan-7-yl]methanone;[6-methyl-3-(1,3-oxazol-2-yl)-2-pyridinyl]-[2-[(5-methyl-2-pyridinyl)oxymethyl]-7-azabicyclo[2.2.1]heptan-7-yl]methanone;[2-[(5-methyl-2-pyridinyl)oxymethyl]-7-azabicyclo[2.2.1]heptan-7-yl]-(6-methyl-3-pyrimidin-2-yl-2-pyridinyl)methanone
CID 158291567
[2-[(5-Fluoro-2-pyridinyl)oxymethyl]-7-azabicyclo[2.2.1]heptan-7-yl]-[6-methyl-3-(3-methyl-1,2,4-oxadiazol-5-yl)-2-pyridinyl]methanone;[2-[(5-fluoro-2-pyridinyl)oxymethyl]-7-azabicyclo[2.2.1]heptan-7-yl]-[6-methyl-3-(3-methyl-2-pyridinyl)-2-pyridinyl]methanone;[2-[(5-fluoro-2-pyridinyl)oxymethyl]-7-azabicyclo[2.2.1]heptan-7-yl]-[6-methyl-3-(1,3-oxazol-2-yl)-2-pyridinyl]methanone;[2-[(5-fluoro-2-pyridinyl)oxymethyl]-7-azabicyclo[2.2.1]heptan-7-yl]-(6-methyl-3-pyrimidin-2-yl-2-pyridinyl)methanone
CID 158648144
tert-butyl 3-(1-adamantylamino)-4-(cyclohexylmethyl)benzoate;tert-butyl 4-(1-adamantylmethyl)-3-[(2,6-dimethylphenyl)methylamino]benzoate;N-cyclohexyl-2-(cyclohexylmethyl)-5-(4-methyl-1,3-oxazol-2-yl)pyridin-3-amine;2-N-cyclohexyl-5-(3-methyl-1,2,4-oxadiazol-5-yl)-3-N-pentan-3-ylpyridine-2,3-diamine;2-N,3-N-dicyclopentyl-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridine-2,3-diamine
CID 158742560
tert-butyl 4-(1-adamantylamino)-3-[(2,6-dimethylphenyl)methylamino]benzoate;2-N-cyclohexyl-5-(3-methyl-1,2,4-oxadiazol-5-yl)-3-N-pentan-3-ylpyridine-2,3-diamine;1-N,2-N-dicyclohexyl-4-(4-methyl-1,3-oxazol-2-yl)benzene-1,2-diamine;2-N,3-N-dicyclopentyl-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridine-2,3-diamine
CID 158815928
8-cyclopentyl-6-[5-(furan-2-yl)-2-pyridinyl]-2-[4-(1-methylpyrrolidin-3-yl)anilino]pyrido[2,3-d]pyrimidin-7-one;6-(1-cyclopropylimidazol-2-yl)-8-ethyl-2-(4-pyrrolidin-3-ylanilino)pyrido[2,3-d]pyrimidin-7-one;8-(cyclopropylmethyl)-2-(4-piperidin-4-ylanilino)-6-[4-(2H-pyrrol-4-yl)phenyl]pyrido[2,3-d]pyrimidin-7-one;8-[2-(dimethylamino)ethyl]-6-[1-methyl-4-(1,3-oxazol-5-yl)imidazol-2-yl]-2-(4-piperazin-1-ylanilino)pyrido[2,3-d]pyrimidin-7-one;8-(oxolan-3-yl)-2-(4-piperidin-3-ylanilino)-6-[2-(3H-pyrrol-5-yl)pyrimidin-5-yl]pyrido[2,3-d]pyrimidin-7-one
CID 159306573
N-cyclohexyl-2-(cyclohexylmethyl)-5-methoxypyridin-3-amine;N-cyclohexyl-2-(cyclohexylmethyl)-5-(4-methyl-1,3-oxazol-2-yl)pyridin-3-amine;2-(cyclohexylmethyl)-N-cyclopentyl-5-(3-methyl-1,2,4-oxadiazol-5-yl)aniline;2-(cyclohexylmethyl)-5-(3-methyl-1,2,4-oxadiazol-5-yl)-N-pentan-3-ylaniline;2-(cyclohexylmethyl)-5-(3-methyl-1,2,4-oxadiazol-5-yl)-N-propan-2-ylpyridin-3-amine
CID 159993852
2-(1-adamantylmethyl)-N-cyclohexyl-5-(4-methyl-1,3-oxazol-2-yl)aniline;N-cyclohexyl-2-(cyclohexylmethyl)-5-(4-methyl-1,3-oxazol-2-yl)pyridin-3-amine;2-N-cyclohexyl-5-(3-methyl-1,2,4-oxadiazol-5-yl)-3-N-pentan-3-ylpyridine-2,3-diamine;2-N,3-N-dicyclopentyl-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridine-2,3-diamine
CID 160010504
6-[1-[4-(4,5-diphenyl-1,3-oxazol-2-yl)butyl]triazol-4-yl]-2-N,4-N-bis(2-methylpropyl)-1,3,5-triazine-2,4-diamine;6-[1-[(4,5-diphenyl-1,3-oxazol-2-yl)methyl]triazol-4-yl]-2-N,4-N-bis(2-methylpropyl)-1,3,5-triazine-2,4-diamine;6-[1-[3-(4,5-diphenyl-1,3-oxazol-2-yl)phenyl]triazol-4-yl]-2-N,4-N-bis(2-methylpropyl)-1,3,5-triazine-2,4-diamine;6-[1-[4-(4,5-diphenyl-1,3-oxazol-2-yl)phenyl]triazol-4-yl]-2-N,4-N-bis(2-methylpropyl)-1,3,5-triazine-2,4-diamine;6-[1-[3-(4,5-diphenyl-1,3-oxazol-2-yl)propyl]triazol-4-yl]-2-N,4-N-bis(2-methylpropyl)-1,3,5-triazine-2,4-diamine
CID 160040822

Frequently Asked Questions

What is the IUPAC name of 1-N-(1-adamantyl)-2-N-cyclohexyl-4-(4-methyl-1,3-oxazol-2-yl)benzene-1,2-diamine;2-N-cyclohexyl-5-(3-methyl-1,2,4-oxadiazol-5-yl)-3-N-pentan-3-ylpyridine-2,3-diamine;2-N,3-N-dicyclohexyl-5-(4-methyl-1,3-oxazol-2-yl)pyridine-2,3-diamine;2-N,3-N-dicyclopentyl-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridine-2,3-diamine?
The IUPAC name of 1-N-(1-adamantyl)-2-N-cyclohexyl-4-(4-methyl-1,3-oxazol-2-yl)benzene-1,2-diamine;2-N-cyclohexyl-5-(3-methyl-1,2,4-oxadiazol-5-yl)-3-N-pentan-3-ylpyridine-2,3-diamine;2-N,3-N-dicyclohexyl-5-(4-methyl-1,3-oxazol-2-yl)pyridine-2,3-diamine;2-N,3-N-dicyclopentyl-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridine-2,3-diamine (CID 162184271) is 1-N-(1-adamantyl)-2-N-cyclohexyl-4-(4-methyl-1,3-oxazol-2-yl)benzene-1,2-diamine;2-N-cyclohexyl-5-(3-methyl-1,2,4-oxadiazol-5-yl)-3-N-pentan-3-ylpyridine-2,3-diamine;2-N,3-N-dicyclohexyl-5-(4-methyl-1,3-oxazol-2-yl)pyridine-2,3-diamine;2-N,3-N-dicyclopentyl-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridine-2,3-diamine.
What is the SMILES notation for 1-N-(1-adamantyl)-2-N-cyclohexyl-4-(4-methyl-1,3-oxazol-2-yl)benzene-1,2-diamine;2-N-cyclohexyl-5-(3-methyl-1,2,4-oxadiazol-5-yl)-3-N-pentan-3-ylpyridine-2,3-diamine;2-N,3-N-dicyclohexyl-5-(4-methyl-1,3-oxazol-2-yl)pyridine-2,3-diamine;2-N,3-N-dicyclopentyl-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridine-2,3-diamine?
The canonical SMILES for 1-N-(1-adamantyl)-2-N-cyclohexyl-4-(4-methyl-1,3-oxazol-2-yl)benzene-1,2-diamine;2-N-cyclohexyl-5-(3-methyl-1,2,4-oxadiazol-5-yl)-3-N-pentan-3-ylpyridine-2,3-diamine;2-N,3-N-dicyclohexyl-5-(4-methyl-1,3-oxazol-2-yl)pyridine-2,3-diamine;2-N,3-N-dicyclopentyl-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridine-2,3-diamine is CCC(CC)Nc1cc(-c2nc(C)no2)cnc1NC1CCCCC1.Cc1coc(-c2ccc(NC34CC5CC(CC(C5)C3)C4)c(NC3CCCCC3)c2)n1.Cc1coc(-c2cnc(NC3CCCCC3)c(NC3CCCCC3)c2)n1.Cc1noc(-c2cnc(NC3CCCC3)c(NC3CCCC3)c2)n1.
What is the InChIKey of 1-N-(1-adamantyl)-2-N-cyclohexyl-4-(4-methyl-1,3-oxazol-2-yl)benzene-1,2-diamine;2-N-cyclohexyl-5-(3-methyl-1,2,4-oxadiazol-5-yl)-3-N-pentan-3-ylpyridine-2,3-diamine;2-N,3-N-dicyclohexyl-5-(4-methyl-1,3-oxazol-2-yl)pyridine-2,3-diamine;2-N,3-N-dicyclopentyl-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridine-2,3-diamine?
The InChIKey is ZPLJYUMANZIKKL-UHFFFAOYSA-N. The full InChI is InChI=1S/C26H35N3O.C21H30N4O.C19H29N5O.C18H25N5O/c1-17-16-30-25(27-17)21-7-8-23(24(12-21)28-22-5-3-2-4-6-22)29-26-13-18-9-19(14-26)11-20(10-18)15-26;1-15-14-26-21(23-15)16-12-19(24-17-8-4-2-5-9-17)20(22-13-16)25-18-10-6-3-7-11-18;1-4-15(5-2)22-17-11-14(19-21-13(3)24-25-19)12-20-18(17)23-16-9-7-6-8-10-16;1-12-20-18(24-23-12)13-10-16(21-14-6-2-3-7-14)17(19-11-13)22-15-8-4-5-9-15/h7-8,12,16,18-20,22,28-29H,2-6,9-11,13-15H2,1H3;12-14,17-18,24H,2-11H2,1H3,(H,22,25);11-12,15-16,22H,4-10H2,1-3H3,(H,20,23);10-11,14-15,21H,2-9H2,1H3,(H,19,22).
What are the key properties of 1-N-(1-adamantyl)-2-N-cyclohexyl-4-(4-methyl-1,3-oxazol-2-yl)benzene-1,2-diamine;2-N-cyclohexyl-5-(3-methyl-1,2,4-oxadiazol-5-yl)-3-N-pentan-3-ylpyridine-2,3-diamine;2-N,3-N-dicyclohexyl-5-(4-methyl-1,3-oxazol-2-yl)pyridine-2,3-diamine;2-N,3-N-dicyclopentyl-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridine-2,3-diamine?
1-N-(1-adamantyl)-2-N-cyclohexyl-4-(4-methyl-1,3-oxazol-2-yl)benzene-1,2-diamine;2-N-cyclohexyl-5-(3-methyl-1,2,4-oxadiazol-5-yl)-3-N-pentan-3-ylpyridine-2,3-diamine;2-N,3-N-dicyclohexyl-5-(4-methyl-1,3-oxazol-2-yl)pyridine-2,3-diamine;2-N,3-N-dicyclopentyl-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridine-2,3-diamine has a molecular weight of 1430.99 g/mol, XLogP of 21.24, 22 rotatable bonds, 8 hydrogen bond donors, and 21 hydrogen bond acceptors.
Where does this data come from?
All data for 1-N-(1-adamantyl)-2-N-cyclohexyl-4-(4-methyl-1,3-oxazol-2-yl)benzene-1,2-diamine;2-N-cyclohexyl-5-(3-methyl-1,2,4-oxadiazol-5-yl)-3-N-pentan-3-ylpyridine-2,3-diamine;2-N,3-N-dicyclohexyl-5-(4-methyl-1,3-oxazol-2-yl)pyridine-2,3-diamine;2-N,3-N-dicyclopentyl-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridine-2,3-diamine is sourced from PubChem (CID 162184271), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).